证券日报网讯12月22日，中设股份（002883）在互动平台回答投资者提问时表示，12月19日收盘后公司 股东人数为18021户。 ...

证券日报网讯12月2日，中设股份（002883）在互动平台回答投资者提问时表示，11月28日收盘后公司 股东人数为19728户。 ...

Market Overview - The engineering consulting services sector experienced a decline of 0.67% on November 27, with 招标股份 leading the drop [1] - The Shanghai Composite Index closed at 3875.26, up 0.29%, while the Shenzhen Component Index closed at 12875.19, down 0.25% [1] Stock Performance - Notable gainers in the engineering consulting services sector included 启迪设计, which rose by 6.39% to a closing price of 17.16, with a trading volume of 245,000 shares and a turnover of 400 million yuan [1] - Other gainers included 矩阵股份 (+2.52%), 示州规划 (+2.11%), and 太极实业 (+1.80%) [1] - Conversely, 招标股份 saw a significant decline of 11.60%, closing at 15.39, with a trading volume of 424,400 shares and a turnover of 662 million yuan [2] Capital Flow - The engineering consulting services sector experienced a net outflow of 10.33 million yuan from institutional investors, while retail investors saw a net outflow of 34.24 million yuan [2] - In contrast, speculative funds recorded a net inflow of 44.57 million yuan [2] Individual Stock Capital Flow - 太极实业 had a net outflow of 59.28 million yuan from institutional investors, while 启迪设计 saw a net inflow of 42.18 million yuan [3] - Other stocks like 深城交 and 汉嘉设计 also experienced varying degrees of net inflow and outflow from different investor categories [3]

Core Viewpoint - The company focuses on providing comprehensive engineering design consulting and general contracting services across four major business areas: transportation, municipal, construction, and environment [2] Group 1: Business Focus - The company emphasizes infrastructure construction in urban and transportation sectors, offering engineering design consulting services [2] - The company aims to support the development of livable cities and integrated transportation systems by providing "all-round, whole process, and full lifecycle" solutions and technical support [2]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带责任。 重要内容提示： 1、为尊重中小投资者利益，提高中小投资者对公司股东会决议重大事项的 参与度，本次股东会审议的议案对中小投资者单独计票。中小投资者是指除上市 公司董事、高级管理人员以及单独或者合计持有公司 5%以上股份的股东以外的 其他股东； 2、本次股东会无否决或修改提案的情况； 证券代码：002883 证券简称：中设股份 公告编号：2025-056 江苏中设集团股份有限公司 2025 第三次临时股东会决议公告 3、本次股东会未涉及变更前次股东会决议的情况。 一、会议召开和出席情况 (一)召开情况 1、会议召开时间： 现场会议召开时间：2025 年 11 月 17 日下午 2：30 开始 网络投票时间：2025 年 11 月 17 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 11 月 17 日上午 9:15-9:25，9:30-11:30，下午 1:00-3:00；通过深圳证券交易所互 联网投票系统进行网络投票的具体时间为 2025 年 ...

国浩律师（上海）事务所 股东会法律意见书 国浩律师（上海）事务所 关于 江苏中设集团股份有限公司 2025 年第三次临时股东会的 法律意见书 关于江苏中设集团股份有限公司 2025 年第三次临时股东会的法律意见书 致：江苏中设集团股份有限公司 江苏中设集团股份有限公司（以下简称"公司"）2025 年第三次临时股东 会现场会议于 2025 年 11 月 17 日（星期一）在江苏省无锡市滨湖区兴阳路 1 号 会议室召开。国浩律师（上海）事务所（以下简称"本所"）接受公司的委托， 指派王琛律师、王浚曦律师（以下简称"本所律师"）出席会议并见证。现依据 《中华人民共和国公司法》《中华人民共和国证券法》和《江苏中设集团股份有 限公司章程》（以下简称《公司章程》）出具本法律意见书。 本所律师按照有关法律、法规及规范性文件的规定对本次股东会的召集、召 开程序是否合法及是否符合《公司章程》的规定、出席会议人员资格的合法有效 性和表决程序的合法有效性发表法律意见。 本所律师是根据对事实的了解和对法律的理解发表法律意见。 中国 上海 山西北路 99 号苏河湾中心 MT 28 层 邮编：200085 电话: (8621) 5234 ...

Core Viewpoint - Jiangsu Zhongshe Group Co., Ltd. (stock code: 002883) announced that its controlling shareholder's action partner, Wuxi Juhang Investment Partnership, received warning letters from the Jiangsu Securities Regulatory Bureau and the Shenzhen Stock Exchange for failing to comply with regulations during a share acquisition process [1][2]. Group 1 - Wuxi Juhang Investment increased its shareholding in Zhongshe Group from 24.63% to 25.62% between September 24 and September 30, 2025, without halting trading when the combined shareholding reached 25% [2]. - The actions of Wuxi Juhang Investment violated the regulations outlined in the "Measures for the Administration of Acquisitions of Listed Companies," specifically regarding the requirement to stop trading and disclose changes in equity when reaching a certain shareholding threshold [2][3]. - The Jiangsu Securities Regulatory Bureau issued a warning letter based on the violation, and Wuxi Juhang Investment is required to submit a written report within 10 working days [3]. Group 2 - The Shenzhen Stock Exchange highlighted that Wuxi Juhang Investment's actions contravened multiple articles of the "Stock Listing Rules (2025 Revision)," emphasizing the need for compliance in stock trading and timely information disclosure [3]. - Wuxi Juhang Investment expressed its commitment to enhancing compliance awareness and adhering to relevant laws and regulations to prevent future violations [3]. - Zhongshe Group reassured investors that the regulatory matters would not impact its normal production and operational activities [3].

股票代码：002883 股票简称:中设股份 公告编号：2025-055 江苏中设集团股份有限公司 关于控股股东之一致行动人无锡炬航投资合伙企业（有限合伙） 收到江苏证监局警示函和深交所监管函的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 江苏中设集团股份有限公司（以下简称"公司"）控股股东之一致行动人无 锡炬航投资合伙企业（有限合伙）（以下简称"炬航投资"）近日收到中国证券监 督管理委员会江苏监管局（以下简称"江苏证监局"）下发的《江苏证监局关于 对无锡炬航投资合伙企业（有限合伙）采取出具警示函措施的决定》（〔2025〕195 号）（以下简称"《警示函》"）和深圳证券交易所出具的《关于对无锡炬航投资合 伙企业（有限合伙）的监管函》（公司部监管函〔2025〕第 187 号）（以下简称"《监 管函》"），现将有关情况公告如下： 一、《警示函》的主要内容 无锡炬航投资合伙企业（有限合伙）： 我局在日常监管中发现，你公司于 2025 年 9 月 24 日至 9 月 30 日期间，通 过集中竞价交易方式增持江苏中设集团股份有限公司（以下简称中设股份）股票 2,1 ...

Core Points - The company reported that as of the close on November 10, the number of shareholders was 21,038 [2] Company Information - The company, Zhongshi Co., responded to investor inquiries on November 11 regarding its shareholder count [2]

Core Viewpoint - The article highlights significant developments in Chongqing, including administrative adjustments and initiatives to support the innovative pharmaceutical industry, which are expected to drive economic growth and enhance the city's development strategy [3][6][10]. Administrative Adjustments - On November 6, Chongqing announced administrative adjustments involving the establishment of the Liangjiang New Area, which will incorporate parts of Jiangbei District and Yubei District, aiming to optimize urban space and functions [6][7]. - The adjustments are designed to enhance the coordination between the Liangjiang New Area and surrounding districts, promoting integrated development and creating a core growth engine for the city [8][9]. Innovative Pharmaceutical Industry Initiatives - The Chongqing government released measures to support the high-quality development of innovative drugs, aiming to approve 1-3 new drugs annually by 2027 and establish a comprehensive innovation ecosystem [10][11]. - Financial incentives include funding support for various stages of drug development, with a maximum of 1 million yuan per project for late-stage clinical trials [10][11]. - The measures also emphasize the integration of artificial intelligence in drug development, aiming to create a comprehensive AI-driven pharmaceutical research system [12][13].